CHICAGO--(BUSINESS WIRE)--CytoCore Inc. (OTCBB:CYOE), the developer of a suite of cost-effective cervical cell collection devices for the early detection of cancer and sexually transmitted diseases, today reported 2007 year-end financial results. The company also provided an update on the progress it has made in expanding its presence within the global medical device market, including initial international distribution and new FDA approval.
